Particles with at least one dimension <100 nanometers, derived from anthropogenic sources (combustion, industrial processes, consumer products) or engineered materials. Nanoparticles represent a novel class of environmental AMP (anthropogenic factors) because the immune system has no evolutionary receptors to recognize or process them, leading to chronic low-grade inflammation and tissue damage.
Nanoparticles bypass normal barrier defenses due to their extremely small size: (1) Cross pulmonary epithelium into circulation via alveolar macrophages or direct transcytosis, (2) Cross blood-brain barrier, accumulating in brain tissue, (3) Translocate across gut epithelium, (4) Penetrate skin barriers. Once in tissues, nanoparticles trigger: (1) Oxidative stress via ROS generation, (2) NLRP3 inflammasome activation, (3) Frustrated phagocytosis (macrophages cannot digest inert particles), (4) Chronic inflammatory signaling (IL-1β, TNF-α, IL-6), (5) Autophagy dysfunction, (6) Mitochondrial damage, (7) DNA damage and genotoxicity. The immune system lacks pattern recognition receptors (PRRs) for synthetic nanoparticles, making them invisible to normal immune tolerance mechanisms while still triggering danger signals.
Nanoparticles are ubiquitous in modern environments (air pollution, food packaging, cosmetics, sunscreens, textiles) and represent a non-influenceable AMP contributing to chronic disease burden. Exposure is associated with cardiovascular disease, neurodegenerative disease, autoimmune conditions, and cancer. In cPNI, reducing exposure where possible (air filtration, organic foods, clean personal care products) and supporting detoxification pathways (glutathione, autophagy, liver function) is essential. The evolutionary mismatch is profound: human immune systems evolved for billions of years with only natural particulates (dust, pollen, bacteria)—synthetic nanoparticles are entirely novel.